Abstract: BACKGROUND Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVC/D) is a mainly autosomal-dominant disease characterized by fibrofatty infiltration of the right ventricle leading to ventricular arrhythmias. Mutations in desmosomal proteins can be identified in about half of the patients. The pathogenic mechanisms leading to disease expression remain unclear. OBJECTIVE To investigate myocardial expression profiles of candidate molecules involved in the pathogenesis of ARVC/D. METH-ODS Myocardial mRNA expression of 62 junctional molecules, five cardiac ion channel molecules, eight structural molecules, four apoptotic molecules and six adipogenic molecules was studied. The averaged expression of candidate mRNAs between ARVC/D samples (n=10), non-familial dilated cardiomyopathy (DCM) samples (n=10) and healthy control samples (n=8) were compared. Immunohistochemistry and quantitative protein expression analysis was performed. Genetic analysis using next-generation sequencing was performed in all ARVC/D patients. RESULTS Following mRNA levels were significantly increased in ARVC/D compared to DCM and controls: phospholamban (p=<0.001 vs DCM; p=<0.001 vs controls), tumor protein 53 apoptosis effector (PERP) (p=0.001 vs DCM; p=<0.001 vs controls), and carnitine palmitoyltransferase 1 beta (CPT1B) (p=<0.001 vs DCM; p=0.008 vs controls). Plakophillin-2 (PKP-2) mRNA was downregulated in ARVC/D patients with PKP-2 mutations compared to ARVC/D patients without PKP-2 mutations (p=0.04). Immunohistochemistry revealed significantly increased protein expression of phospholamban, PERP and CPT1B in ARVC/D patients, and decreased PKP-2 expression in ARVC/D patients carrying a PKP-2 mutation. CONCLUSIONS Changes in the expression profiles of sarcolemmal calcium channel regulation, apoptosis and adipogenesis suggest that these molecular pathways may play a critical role in the pathogenesis of ARVC/D, independent of underlying genetic mutations. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting galley proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. 
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting galley proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. which also implicates the variability of clinical phenotypes. 1 The most common mutations involve the PKP2 gene, followed by mutations of the DSG-2 and DSP genes. 2 In cardiomyocytes, the desmosomal cadherins DSG-2 and DSC-2, the plakin DSP, which binds to the intermediate filament DES, the linking armadillo proteins PKP-2 and JUP build desmosomal structures, which are crucial for cardiomyocyte adhesion and mechanical stability. 5 Desmosomal proteins strongly interact with other junctional molecules, such as other cadherins, catenins and gap junction molecules, connexins (Cx) 40, 43 and 45. These functional formations are called connexomes, and the cardiac intercalated disc is likely the host of this complex protein-interacting network. 6, 7 Recent studies have shown that these intercellular formations may also play a role in signal transduction, apoptosis, and adipogenesis. 8 Early histology and electron microscopy studies revealed that the fibrofatty replacement of the right ventricular myocardium is accompanied by inflammation and apoptosis. 9 Desmosomal mutations may lead to altered cellular distribution of desmosomes, as well as increased apoptosis. 10 It has been demonstrated that the tumor protein 53 apoptosis effector (PERP) does not only play a role in the initiation of apoptosis, but is also involved in desmosomal structures. 11 Studies on induced pluripotent stem cells have highlighted that in the acute failing heart, carnitine-palmitoyltransferase-1beta (CPT1B), a molecule leading to mitochondrial long chain fatty acid uptake, may play an important role in fatty acid oxidation. 12 TGFB3, a cytokine involved in the modulation of desmosomal proteins and stimulation of fibrosis has also been reported to have an influence on the pathogenesis of myocardial fibrosis. 13 Experimental and clinical data suggest that other non-junctional cellular structures like the voltage-gated sodium channel (Nav 1.5), the sarcolemmal calcium channel regulating molecule PLN, and structural molecules are linked to desmosomes.
14 Especially PLN phosphorylation has been reported to play a key role in the pathophysiology of heart failure. 15 Taken together, various cellular pathways, particularly electromechanical cell-to-cell coupling, inflammation, apoptosis, adipogenesis and fibrosis seem to be involved in the pathophysiology of ARVC/D, but the interactions are not fully understood. Therefore, the aim of this study was to identify dysregulated myocardial molecules associated with the mentioned pathways ARVC/D by investigating the myocardial expression profiles of various candidate proteins using an mRNA expression and immunolocalization approach.
Methods

Human myocardial tissue samples
10 patients with a definite diagnosis of ARVC/D were included in this study (Table 1) . 16 In five of these, right ventricular myocardial samples were obtained by endomyocardial biopsy, in the others during transplantation. were spanning an exon-exon junction and amplified a maximal amplicon length of 200 nt.
Two housekeeping genes glyceraldehyde-3-phosphate-dehydrogenase and 18srRNA were taken as individual references to adjust and normalize each primer RNA, the more stable housekeeping gene was used for data calculation. mRNA measurement was performed with 7900HT fast real-time PCR system (Applied Biosystems, Zug, Switzerland). Arbitrary units (AU) were calculated according to the delta cycle of threshold (ct) method: AU=2 (-Δct) ×1000.
Higher AU represented higher mRNA expression, and AU between 0-5 was considered as very low or no expression. 21 All mRNA data is presented in Supplementary Table 2 .
Immunohistochemistry and confocal microscopy
Formalin fixed and paraffin embedded tissue samples were cut into 5 µm sections.
Deparaffinization was conducted using xylol and isopropanol. Slides were then cooked in citrate buffer for antigen retrieval and blocked with 10% goat serum. relatively to control healthy tissue samples using Image J software. This software has been validated for image analysis that allows quantification of total tissue fluorescence. 22 Relative signal intensities were measured by two independent investigators blinded to the clinical data. The results were validated by another blinded observer.
Data analysis
Statistical analysis was performed using GraphPad Prism 5.0. Values are given as mean ± standard error (SEM) or standard deviation (SD). Statistical comparison between the three groups (ARVC/D, DCM, control) was performed using the Mann-Whitney U test. Statistical significance was assumed for p values < 0.05.
Results
Patient characteristics
Clinical characteristics of ARVC/D patients are presented in Table 1 (Table 1 and supplementary Table 3 ). All DCM patients had a clinical and histological diagnosis of DCM but no right ventricular involvement. None of the DCM patients had ischemic, toxic or hypertensive origin of DCM, and none of them had a family history of DCM. All DCM tissue was tested for enterovirus, adenovirus, parvovirus b19, human herpesvirus 6, herpes simplex virus 1/ 2, Epstein-Barr virus, human cytomegalovirus, varicella zoster virus, influenza virus, and borrelia burgdorferi and toxoplasma gondii. In three patients a viral origin was assumed, in the remaining idiopathic DCM was suspected.
Genetic mutations
All genetic variants and mutations found in our cases are listed in Table 2 
mRNA expression of molecules associated with ion channels and cellular structures
In a further step, we investigated dysregulations in other cellular pathways, since ARVC/D causing mutations have also been reported in ion channels and structural molecules. 2 From the ion channel molecules, the calcium channel regulating protein PLN showed a significantly higher mRNA expression in ARVC/D compared to DCM and control hearts, but no difference between controls and DCM ( Table 3A) . There was no significant difference in RYR2, nav 1.5, striatin (STRN) and ankyrin-g (ANK-G) expression (Figure 2A) . From the structural molecules, we screened DES, TTN, plectin (PLEC), laminin alpha (LAMA) -2 and -4, transmembrane protein (TMEM) 43 and 234, and TGFB3 ( Figure 2B ), but we did not find any significant differences between the three groups.
mRNA expression of molecules regulating apoptosis and adipogenesis
Molecules involved in apoptosis and adipogenesis were also investigated, since these (Table 3A) , the other adipogenic molecules did not differ between groups. We also measured mRNA expression of common inflammatory cytokines interferon-α, β and J, tumor necrosis factor, interleukin-6 and the antiinflammatory interleukin-10. These molecules had no detectable expression in ARVC/D, DCM and controls.
mRNA and protein expression in ARVC/D patients with pathogenic PKP2 mutations
Since, in most cohorts, PKP-2 mutations are the most common genetic cause of ARVC/D, we performed sub analyses of mRNA expression in patients with PKP2 mutations in our cohort.
We were able to demonstrate that mRNA expression of PLN and PERP was significantly increased in this cohort. The mRNA level of CPT1B was significantly increased compared to DCM tissue, and showed a trend towards increased levels compared to controls ( Figure 3A , Table 3B ). 
Desmosomal molecules
A complex network of molecular interactions that involve junctional molecules inside intercalated discs is currently considered to underlie the pathophysiology of ARVC/D. Cell junctions, intracellular structures linked to the area composita, ion channels, apoptosis, and adipogenesis are likely to play an important part. 2 Recent studies highlight that desmosomal mutations may lead to a remodelling inside the area composita and a defective distribution of ion channel molecules, but not necessarily to decreased levels of other desmosomes in general. 24 In line with those studies, our analysis revealed that in patients with ARVC/D, there is no general decrease in all desmosomal mRNAs, but that pathogenic desmosomal nonsense or frameshift mutations may lead to decreased levels of those particular desmosomal molecules.
25,26
Phospholamban PLN is a protein linked to the sarcoplasmatic reticulum, inhibiting the calcium intake when dephosphorylated, and increasing myocardial contractility through calcium intake when phosphorylated. Although PLN is a major determinant of cardiac contractility and relaxation, it remains controversial whether heart failure leads to decreased PLN levels or vice versa, and whether the amount of phosphorylation may differ. It has been shown that decreased phosphorylation of PLN, and an increase of the PLN to Ca 2+ ATPase pump ratio leads to contractile dysfunction. 15 In vitro studies have revealed that higher phosphorylation levels of PLN lead to improved contractility, and that its dephosphorylation may promote heart failure. for dysfunctional intercalated discs. This hypothesis has to be investigated in future studies.
Apoptosis and adipogenesis
PERP, a proapoptotic molecule essential for p53-induced cell death, and with a recently described role in cell adhesion 11 , was also increased in ARVC/D in our study. PERP was upregulated on both mRNA and protein levels, independent of the underlying mutation in all patients. This upregulation underscores an important role of apoptosis in the failing right ventricular myocardium of patients with ARVC/D. 23, 29 As PERP is involved in cell adhesion, it could also be increased due to desmosomal malfunction, which is supported by the notion that other proapoptotic molecules were not significantly upregulated.
Moreover, we observed an increase of CPT1B mRNA and protein levels in our ARVC/D patients compared to DCM and controls, suggesting that this adipogenic factor may play a role in the pathophysiology of ARVC/D. It has been reported that alterations in transmembrane proteins and desmosomes may lead to changes in cell signalling, and to adipogenic/fibrogenic proliferation or an imbalance of fatty acid oxidation due to changes in PPAR molecules. 30, 31 In our study, we did not find a change in the mRNA expression of any PPAR molecule, but increased levels of the CPT1B molecule. Patient specific induced pluripotent stem cell studies revealed that co-activation of PPAR-D and J lead to CPT1B downregulation in an advanced-stage ARVC/D model. 12 This in vitro study was based on severe PKP-2 mutations, and thus differs from our in vivo study in humans with variable desmosomal and non-desmosomal mutations. It may be speculated that CPT1B upregulation precedes downregulation in ARVC/D, as our ARVC/D patients generally did not display failing hearts. Furthermore, increased long chain fatty acid uptake into mitochondria may promote myocardial adipogenesis. Accordingly, studies have shown beneficial effects of inhibiting various steps of fatty acid oxidation in the progression of heart failure.
32
Genetic mutations
In ARVC/D it is known that a radical mutation in desmosomal genes may be sufficient to yield the phenotype. Nonetheless, it has been reported that multiple variants can play a role as disease modifiers. 33 Mutations in non-desmosomal genes represent a challenge in interpretation. Radical mutations in TTN have a higher likelihood to be disease causing, nevertheless several missense mutations in TTN have also been recognized as pathogenic.
34
Study limitations: The difficulty and safety aspects to obtain endomyocardial biopsies, myocardial explant and autopsy material from patients with this rare disease allowed access to a relatively low number of patients, particularly limiting subgroup analysis. Yet, subgroup analyses in patients with the same type of mutation in a wider range would be desirable in ARVC/D due to its high genetic heterogeneity. Furthermore, contamination with fibrous and endothelial tissue was present to some extent, although this was minimized through microscopic investigation. However, in spite of these limitations, we were able to show coherent and specific findings in myocardial tissue of patients with ARVC/D independent of underlying mutations.
Conclusions
This study demonstrates for the first time that PLN, PERP and CPT1B mRNA and protein expression is increased in right ventricular myocardial tissue of patients with ARVC/D compared to DCM and healthy controls, independent of the underlying genetic mutation.
These results indicate that common pathophysiologic pathways involving sarcolemmal calcium channel regulation, apoptosis and adipogenesis may exist in this genetically heterogeneous disease.
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